Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Net Income towards Common Stockholders of $57000.0 for Q4 2025, up 101.8% year-over-year from $28245.7 in Q4 2024, and down 95.64% quarter-over-quarter from $1.3 million in Q3 2025.
Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Net Income towards Common Stockholders for 16 consecutive years, with $57000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Income towards Common Stockholders rose 101.8% year-over-year to $57000.0; the TTM figure through Dec 2025 stood at $5.0 million (up 130.23% YoY), while the FY2025 annual figure was $5.0 million, up 130.23% from the prior year.
- Net Income towards Common Stockholders declined to $57000.0 in Q4 2025 per XTNT's latest filing, from $1.3 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $9.2 million in Q3 2023 and bottomed at -$6.2 million in Q4 2023.
- Historically, Net Income towards Common Stockholders has averaged -$1.3 million across 5 years, with a median of -$1.9 million in 2021.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 7531.03% — and 2023, when it soared 492.31%.
- Xtant Medical Holdings' Net Income towards Common Stockholders stood at -$1.3 million in 2021, then sank by 74.62% to -$2.2 million in 2022, then tumbled by 180.85% to -$6.2 million in 2023, then soared by 48.98% to -$3.2 million in 2024, then surged by 101.8% to $57000.0 in 2025.
- Business Quant data shows XTNT's Net Income towards Common Stockholders at $57000.0 in Q4 2025, $1.3 million in Q3 2025, and $3.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Xtant Medical Holdings | 46.30 Mn | 28.69 Mn | 17.75 Mn | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,000.00 |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | -3.17 Mn |
| Sep 30, 2024 | -5.02 Mn |
| Jun 30, 2024 | -3.86 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -6.20 Mn |
| Sep 30, 2023 | 9.23 Mn |
| Jun 30, 2023 | -2.19 Mn |
| Mar 31, 2023 | -2.08 Mn |
| Dec 31, 2022 | -2.21 Mn |
| Sep 30, 2022 | -2.35 Mn |
| Jun 30, 2022 | -1.71 Mn |
| Mar 31, 2022 | -2.21 Mn |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.80 Mn |
| Jun 30, 2021 | -733,000.00 |
| Mar 31, 2021 | -29,000.00 |